Glucose Promotes Breast Cancer Aggression and Reduces Metformin Efficacy

Cited by (125)

Items 101–125 of 125

1. Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non‐TNBC
   Jin Hui Yu, Shuoqing Fan, Wenna Jiang, Jingya Zhang, Lexin Yang, Jiawei Xiao, Haohua An, Li Ren · 2022 · PROTEOMICS - CLINICAL APPLICATIONS
2. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies
   Lingna Li, Jianing Huang, Tongmin Huang, Jie Yao, Yeyuan Zhang, Meiling Chen, Haojie Shentu, Haiying Lou · 2023 · International Journal of Endocrinology
3. Glycemic load impacts the response of acquired resistance in breast cancer cells to chemotherapeutic drugs in vitro
   Sirin A. Adham, Azzam Yousuf Salim Al Kalbani, Noura Al‐Zeheimi, Muna Al Dalali, Noor Al Kharusi, Azeeza Siddiqi, Aliya Al Maskari · 2024 · PLoS ONE
4. Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
   Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
5. Potential and real ‘antineoplastic’ and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females
   Lev M. Berstein, D. A. Vasilyev, Aglaya G. Iyevleva, Marina P. Boyarkina, Порошина Татьяна Евгеньевна, A S Khadzhimba, Евгений Наумович Имянитов · 2015 · Future Oncology
6. Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
   Lev Mikhaylovich Bershteyn, Д. А. Васильев, Aglaya G. Iyevleva, Порошина Татьяна Евгеньевна, Евгений Наумович Имянитов · 2014 · Diabetes Mellitus
7. FASNating Targets of Metformin in Breast Cancer Stem-Like Cells
   Elizabeth A. Wellberg, Steven Michael Anderson · 2014 · Hormones and Cancer
8. Metformin Induces Ferroptosis and Inhibits Malignant Progression in Diabetic Breast Cancer
   Tao Chen, Xiaoxin Li, Mengyao Zhou, Chunyan Zhou, Xing Wang, Changwen Li · 2026 · Applied Biochemistry and Biotechnology
9. Administration of metformin to increase the efficacy of chemotherapy regimen in cancers; a new look to an old drug
   Niloufar Hooshyar, Ramin Tolouian, Behzad Ghasemi, Nafiseh Nowrouzi, Banafsheh Yalameha, Mohammadreza Khosravifarsani, Parto Nasri · 2019 · Immunopathologia Persa
10. Metformin as an adjuvant option for systemic treatment of breast cancer
    D. I. Avierin, В. Ф. Завізіон · 2023 · Medicni perspektivi
11. Investigating the Inhibitory Aspects of Metformin/Curcumin Co-Treatment through Convergence of In-Silico and In-Vitro Approaches
    Farzaneh Afzali, Zahra Nayeri, Zarrin Minuchehr, Mossa Gardaneh · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
12. The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer
    Lisa D. Kellenberger · 2016 · The Atrium (University of Guelph)
13. TKTL1 — Schlüsselenzym in der Onkologie
    Andre-R. Rotmann, Steffen Wagner, Heiko Hofmann, Johannes F. Coy · 2014 · gynäkologie + geburtshilfe
14. Flow Cytometry of Breast Cancer Resistant Protein and microRNA in Breast Cancer Patients Post Metformin Effect
    Bassent Gamal Abdel Nasser Mohammed, Ashour Abdel Salam Abdel Mawla, Sameh Ibrahim Zaki, Mohamed Atteya Saad Atteya · 2016 · European Scientific Journal ESJ
15. Epigenetic regulation of resistance to treatments in triple negative and HER2+ breast cancer: miRNAs involved
    Paula Cabello Navarro · 2020
16. TNBC: A brief discussion on Triple Negative Breast Cancer
    Dipty Tandi · 2021 · International Journal of Advanced Multidisciplinary Research
17. Bedeutung der Glukoseaufnahme und Glykolyse für die Leukämogenese in der adulten Akuten Lymphatischen Leukämie der B-Zellen
    Tabea Sabine Thomas · 2022
18. The development and application of a ChIP and MeDIP assay to determine a link between epigenetics and metabolism in ovarian cancer progression
    TSE, CARMEN · 2022
19. Data from Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers
    Reema S. Wahdan-Alaswad, Susan M. Edgerton, Hiba Salem, Hyunmin Kim, Aik Choon Tan, Jessica Finlay-Schultz, Elizabeth A. Wellberg, Carol A. Sartorius, Britta M. Jacobsen, Bryan R. Haugen et al. · 2023
20. Data from Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers
    Reema S. Wahdan-Alaswad, Susan M. Edgerton, Hiba Salem, Hyunmin Kim, Aik Choon Tan, Jessica Finlay-Schultz, Elizabeth A. Wellberg, Carol A. Sartorius, Britta M. Jacobsen, Bryan R. Haugen et al. · 2023
21. Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
    Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, Komal Raina · 2023 · Current Pharmacology Reports
22. ОЦІНКА ЕФЕКТИВНОСТІ МЕТФОРМІНУ У КОМБІНОВАНОМУ ЛІКУВАННІ РАКУ МОЛОЧНОЇ ЗАЛОЗИ: АНАЛІЗ ПАТОМОРФОЛОГІЧНИХ МАРКЕРІВ ТА РОЗРОБКА МАТЕМАТИЧНОЇ МОДЕЛІ ПРОГНОЗУВАННЯ
    D. I. Avierin, В. Ф. Завізіон · 2024 · Перспективи та інновації науки
23. Metformin induces ferroptosis and suppresses malignant behaviors in diabetic breast cancer
    Tao Chen, Xiaoxin Li, Yuanyuan Li, Chunyan Zhou, Chuangang Tang, Xiang Wang, Changwen Li · 2024 · Research Square
24. Hábitos de vida e suas relações com grandes deleções e amplificações na determinação do câncer de pele: um estudo piloto
    Christopher William Lee, Carlos Henrique Schneider, Maria Leandra Terêncio, Patrícia Oliveira de Paula, Luís Fernando Boff Zarpelon, Maria Cláudia Gross · 2024 · Caderno Pedagógico
25. A Promising Insight into the Treatment of Triple-negative Breast Cancer with Curcumin loaded 1,4-Bis(3-aminopropyl) Piperazine Functionalized-graphene Quantum Dots: Synthesis, Cytotoxicity and In Silico Analyses
    Dilara Alver, Pınar Şen, Serap Yalçın Azarkan, Dolunay Şakar, Muhsin Konuk · 2026 · Journal of Pharmaceutical Innovation